A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

NCT04888949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection( COVID-19 )

Interventions

BIOLOGICAL: Mesenchymal stem cell
BIOLOGICAL: Placebo

Sponsor

Rohto Pharmaceutical Co., Ltd.